Hepcvel Sofosbuvir And Velpatasvir 28 Tablet

Get a Price/Quote

MOQ : 10 Boxes

Hepcvel Sofosbuvir And Velpatasvir 28 Tablet Specification

Dosage Form
Tablet

Indication
Chronic Hepatitis C Virus (HCV) infection

Salt Composition
Sofosbuvir 400 mg + Velpatasvir 100 mg

Feature
Fixed-dose combination for broad spectrum HCV treatment

Application
Antiviral therapy for patients with HCV

Physical Color/Texture
Film-coated tablet

Storage Instructions
Store below 30C, protect from moisture and sunlight

Shelf Life
24 months

Marketed By
Cipla Ltd.

Country Availability
Available internationally including Canada, EU, UK, USA, Australia

Prescription Required
Yes

Therapeutic Class
Antiviral/Direct-acting antiviral

Patient Suitability
Adults with all genotypes of HCV

Color
Varies (commonly yellow, film-coated)

Warning
Should not be used in patients with hypersensitivity to any component

Administration Route
Oral

Compatibility
Can be used in patients co-infected with HIV

Pack Size
28 Tablets/box

Hepcvel Sofosbuvir And Velpatasvir 28 Tablet Trade Information

Minimum Order Quantity
10 Boxes

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Boxes Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

Hepcvel Sofosbuvir And Velpatasvir 28 Tablet About

Unlock a pivotal approach to chronic HCV therapy with Hepcvel Sofosbuvir and Velpatasvir 28 Tablet. This versatile, fixed-dose combination is expertly tailored for adults of all HCV genotypes-even those co-infected with HIV. Sizzling with efficacy, its ace formula blends Sofosbuvir 400 mg and Velpatasvir 100 mg, elevating treatment standards. Customizable for global needs and backed by Cipla's excellent reputation, Hepcvel ensures reliable therapy. Store this film-coated tablet below 30C, shielded from sunlight, for optimal stability. Prescription-only, for oral use.

Comprehensive Antiviral Solution for Diverse Applications

Hepcvel Sofosbuvir and Velpatasvir 28 Tablet is engineered for oral use and serves as a broad-spectrum antiviral therapy targeting chronic Hepatitis C virus (HCV) infections. Suited for adult patients, it delivers strong efficacy across all HCV genotypes. The film-coated tablets are especially beneficial for those who require direct-acting antiviral solutions, including HIV co-infected individuals. The application surface is medicinal, ensuring direct, patient-focused action during therapy cycles.

Certifications, Export Markets, and Reliable Supply Chain

Hepcvel is internationally certified to meet pivotal pharmaceutical standards and is dispatched from India's leading logistics hubs. Available at competitive charge points (FOB), it is supplied to major export markets including Canada, the EU, UK, USA, and Australia. Consistent supply ensures timely access for global healthcare providers, with Cipla Ltd. as the official manufacturer, supplier, and trader, reinforcing trust through every shipment.

FAQ's of Hepcvel Sofosbuvir And Velpatasvir 28 Tablet:

Q: How should Hepcvel Sofosbuvir and Velpatasvir 28 Tablet be administered?

A: Hepcvel is intended for oral administration once daily, as prescribed by a healthcare professional. Always follow your doctor's guidance for optimal results.

Q: What are the main benefits of using Hepcvel for Hepatitis C treatment?

A: Hepcvel offers a fixed-dose, broad-spectrum combination effective across all HCV genotypes and can be used in patients co-infected with HIV. Its excellent efficacy and streamlined oral dosage make it a pivotal option in HCV management.

Q: When is this medication indicated for therapy?

A: Hepcvel is indicated for adults diagnosed with chronic Hepatitis C virus (HCV) infection, regardless of genotype. Its use requires a valid prescription from a healthcare provider.

Q: Where is Hepcvel Sofosbuvir and Velpatasvir 28 Tablet available?

A: Hepcvel is available internationally, reaching key markets like Canada, the European Union, UK, USA, and Australia, ensuring broad patient access.

Q: What precautions should be taken before starting Hepcvel?

A: Patients with known hypersensitivity to any components should avoid Hepcvel. Discuss your full medical history and medications with your healthcare provider before starting therapy.

Tell us about your requirement